EUVIMEDObjevte EUVIMED
Crossref

Rhynchophylline as an agonist of sirtuin 3 ameliorates endothelial dysfunction via antagonizing mitochondrial damage of endothelial progenitor cells

Lin Lin, Bowen Sun, Yuanlong Hu, Wenqing Yang, Jie Li, Danyang Wang, Lei Zhang, Mengkai Lu, Yuan Li, Yunlun Li iD, Dan Zhang, Chao Li

British Journal of Pharmacology · 2025-08 · 182 (15) · 3476-3502

DOI: 10.1111/bph.70032 ↗

At a glance

Journal article in British Journal of Pharmacology, 2025-08. Written by Lin Lin and 11 co-authors. Institution: Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China. Major MEDLINE topics: Sirtuin 3, Endothelial Progenitor Cells, Mitochondria, Oxindoles. Cited 49 times so far (Crossref); 67 references. Funded by: NATCM's Project of High-level Construction of Key TCM Disciplines, National Natural Science Foundation of China, SKRD Program of Shandong Province.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background and Purpose Mitochondrial dysregulation of endothelial progenitor cells (EPCs) has been implicated in endothelial destruction and hypertension. Regulation of silent information regulator 3 (sirtuin 3; SIRT3) in mitochondrial damage of EPCs and the underlying molecular mechanisms remain unclear, and evidence of selective SIRT3 agonists for the treatment of hypertension also is lacking. Experimental Approach Here, we discovered a potent SIRT3 agonist, rhynchophylline (Rhy), and explored its underlying action on mitochondrial damage of EPCs and endothelial dysfunction. Key Results In spontaneously hypertensive rats, Rhy reduced blood pressure and ameliorated vasomotion, paralleling improved EPC function in the peripheral circulation. Moreover, Rhy alleviated mitochondrial damage and inhibited apoptosis via the mitochondrial apoptotic pathway. SIRT3 knockdown interrupted the regulation of mitochondrial homeostasis induced by Rhy, thus abolishing its antagonizing effect on EPC dysfunction and endothelial damage, suggesting that Rhy protection of EPC mitochondria is mediated via the activation of SIRT3. Rhy restrained the production of mitochondrial ROS and improved the activity of superoxide dismutase 2 (SOD2) in a SIRT3‐dependent manner, whereas silencing SOD2 eliminated the inhibition by Rhy of oxidative stress and apoptosis, reflecting that SOD2 was indispensable for the regulation of Rhy on mitochondrial dysfunction and the mitochondrial‐mediated apoptosis pathway. Conclusion and Implications SIRT3‐dependent mitochondrial homeostasis contributes to attenuating hypertension‐related EPC dysfunction and endothelial injury, and Rhy itself is a potent and targeted SIRT3 agonist that prevented mitochondrial dysfunction by regulating the SIRT3/SOD2 pathway, which may provide new clues for drug candidates for hypertension therapeutics.

Subjects

MeSH terms (MEDLINE)

Sirtuin 3Endothelial Progenitor CellsMitochondriaOxindolesIndole AlkaloidsAnimalsMaleRatsRats, Inbred SHRApoptosisSuperoxide DismutaseRats, Inbred WKYCells, CulturedOxidative StressReactive Oxygen SpeciesHypertensionEndothelium, VascularSirtuinsSuperoxide Dismutase 2

Author keywords

SIRT3endothelial progenitor cellshypertensionmitochondriarhynchophylline

Substances

Sirtuin 3OxindolesSuperoxide DismutaseReactive Oxygen SpeciesIndole AlkaloidsSirtuinsSuperoxide Dismutase 2rhyncophyllineSIRT3 protein, rat

Authors and institutions

  • Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Cardiovascular Department, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.

ORCID profiles: Yunlun Li

Funding

  • NATCM's Project of High-level Construction of Key TCM Disciplines
  • National Natural Science Foundation of China
  • SKRD Program of Shandong Province
  • Natural Science Foundation of Shandong Province
  • China Postdoctoral Science Foundation
  • Outstanding Youth Innovation Team of Shandon Institutions of Higher Learning
  • Jinan City School Integration Development Strategy Project

Cite

APA

Lin, L., Sun, B., Hu, Y., Yang, W., Li, J., Wang, D., Zhang, L., Lu, M., Li, Y., Li, Y., Zhang, D., & Li, C. (2025). Rhynchophylline as an agonist of sirtuin 3 ameliorates endothelial dysfunction via antagonizing mitochondrial damage of endothelial progenitor cells. British Journal of Pharmacology. https://doi.org/10.1111/bph.70032

Vancouver

Lin L, Sun B, Hu Y, Yang W, Li J, Wang D, et al. Rhynchophylline as an agonist of sirtuin 3 ameliorates endothelial dysfunction via antagonizing mitochondrial damage of endothelial progenitor cells. British Journal of Pharmacology. 2025. doi:10.1111/bph.70032

BibTeX
@article{Lin2025,
  author = {Lin, Lin and Sun, Bowen and Hu, Yuanlong and Yang, Wenqing and Li, Jie and Wang, Danyang and Zhang, Lei and Lu, Mengkai and Li, Yuan and Li, Yunlun and Zhang, Dan and Li, Chao},
  title = {Rhynchophylline as an agonist of sirtuin 3 ameliorates endothelial dysfunction via antagonizing mitochondrial damage of endothelial progenitor cells},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.70032}
}
Start for free →